Insider · CIK 0001705113
Brian J. Flornes
Files at AHR (American Healthcare REIT, Inc.). First filing -, latest -.
In brief
Brian J. Flornes files SEC Form 4 as director at AHR (American Healthcare REIT, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Brian J. Flornes has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 6 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 24, 2026 | AHR American Healthcare REIT, Inc. | AGrant or award Common Stock | +2,594 | $0.00 | $0 | 33,020 | Jun 26, 2026 |
| Jun 25, 2025 | AHR American Healthcare REIT, Inc. | AGrant or award Common Stock | +3,042 | $0.00 | $0 | 30,426 | Jun 27, 2025 |
| Nov 7, 2024 | AHR American Healthcare REIT, Inc. | AGrant or award Common Stock | +3,610 | $0.00 | $0 | 27,384 | Nov 12, 2024 |
| Aug 5, 2024 | AHR American Healthcare REIT, Inc. | JOther Class T Common Stock | -16,367 | - | - | 0 | Aug 7, 2024 |
| Aug 5, 2024 | AHR American Healthcare REIT, Inc. | JOther Common Stock | +16,367 | - | - | 23,774 | Aug 7, 2024 |
| Feb 9, 2024 | AHR American Healthcare REIT, Inc. | AGrant or award Common Stock | +7,407 | $0.00 | $0 | 7,407 | Feb 13, 2024 |
Questions about Brian J. Flornes
Answered from the filings on this page, as of the latest one.
Is Brian J. Flornes buying or selling?
Brian J. Flornes has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Brian J. Flornes's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian J. Flornes has 0.
Where does Brian J. Flornes file Form 4?
Brian J. Flornes has filed Form 4 at AHR (American Healthcare REIT, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.